Princeton Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$8.38M Buy
131,433
+20,047
+18% +$1.17M 4.24% 5
2017
Q2
$6.21M Buy
111,386
+21,768
+24% +$1.18M 3.91% 5
2017
Q1
$4.87M Buy
89,618
+3,751
+4% +$206K 3.08% 15
2016
Q4
$5.02M Buy
85,867
+4,140
+5% +$226K 3.34% 11
2016
Q3
$4.41M Buy
81,727
+9,211
+13% +$592K 2.88% 15
2016
Q2
$5.33M Sell
72,516
-4,091
-5% -$289K 3.68% 7
2016
Q1
$4.89M Buy
76,607
+1,708
+2% +$108K 3.4% 7
2015
Q4
$5.15M Sell
74,899
-30,893
-29% -$2.04M 3.63% 5
2015
Q3
$6.26M Sell
105,792
-1,675
-2% -$106K 3.79% 5
2015
Q2
$7.15M Buy
107,467
+650
+0.6% +$42.8K 3.78% 6
2015
Q1
$6.89M Buy
106,817
+13,245
+14% +$829K 3.53% 8
2014
Q4
$5.52M Buy
93,572
+16,775
+22% +$946K 3.05% 10
2014
Q3
$3.93M Buy
76,797
+13,070
+21% +$653K 2.51% 15
2014
Q2
$3.09M Buy
63,727
+9,305
+17% +$459K 2.14% 19
2014
Q1
$2.83M Buy
54,422
+6,000
+12% +$319K 2.05% 19
2013
Q4
$2.57M Buy
48,422
+4,770
+11% +$243K 2.06% 19
2013
Q3
$2.02M Buy
43,652
+8,315
+24% +$365K 1.85% 23
2013
Q2
$1.58M Buy
+35,337
New +$1.53M 1.52% 28

Other funds holding BMY

Princeton Capital Management Inc's BMY Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Bristol-Myers Squibb (BMY) stake by 18% in Q3 2017, buying an estimated $1.17M and bringing the position to 131,433 shares worth $8.38M. The position accounts for 4.24% of the portfolio, ranked #5.

Princeton Capital Management Inc first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Princeton Capital Management Inc held 131,433 shares of Bristol-Myers Squibb worth $8.38M as of Q3 2017.
  • Princeton Capital Management Inc bought 20,047 Bristol-Myers Squibb shares in Q3 2017, an estimated $1.17M.
  • Bristol-Myers Squibb made up 4.24% of Princeton Capital Management Inc's portfolio in Q3 2017, its #5 holding.
  • Princeton Capital Management Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.